Novavax, Inc. (NVAX)
NASDAQ
Market Cap
$1.84B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
678 of 809
Rank in Industry
372 of 445
Largest Insider Buys in Sector
NVAX Stock Price History Chart
NVAX Stock Performance
About Novavax, Inc.
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Insider Activity of Novavax, Inc.
Over the last 12 months, insiders at Novavax, Inc. have bought $0 and sold $1.07M worth of Novavax, Inc. stock.
On average, over the past 5 years, insiders at Novavax, Inc. have bought $98,977 and sold $55.68M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,000 shares for transaction amount of $6,500 was made by Glenn Gregory M (President, R&D) on 2023‑03‑10.
List of Insider Buy and Sell Transactions, Novavax, Inc.
| 2024-06-21 | Sale | YOUNG JAMES F | director | 7,500 0.0045% | $14.09 | $105,675 | +0.07% | |
| 2024-06-18 | Sale | YOUNG JAMES F | director | 7,500 0.0044% | $13.72 | $102,881 | +1.60% | |
| 2024-06-17 | Sale | Dubovsky Filip | President, R&D | 13,904 0.0086% | $14.47 | $201,164 | -0.36% | |
| 2024-05-14 | Sale | Dubovsky Filip | President, R&D | 47,312 0.0347% | $13.90 | $657,637 | +11.87% | |
| 2023-03-10 | Glenn Gregory M | President, R&D | 1,000 0.0012% | $6.50 | $6,500 | +9.05% | ||
| 2023-03-07 | Glenn Gregory M | President, R&D | 2,000 0.0023% | $7.04 | $14,088 | +1.72% | ||
| 2023-03-06 | Glenn Gregory M | President, R&D | 3,000 0.0036% | $7.48 | $22,454 | -2.74% | ||
| 2022-03-31 | Sale | YOUNG JAMES F | 300 0.0004% | $75.10 | $22,531 | -69.53% | ||
| 2022-01-03 | Sale | Herrmann John A III | EVP, Chief Legal Officer | 5,000 0.0064% | $140.91 | $704,534 | -65.85% | |
| 2021-12-31 | Sale | YOUNG JAMES F | director | 3,750 0.0049% | $144.16 | $540,601 | -64.98% | |
| 2021-12-20 | Sale | Herrmann John A III | EVP, Chief Legal Officer | 5,000 0.0075% | $230.00 | $1.15M | -74.34% | |
| 2021-12-15 | Sale | Glenn Gregory M | President, R&D | 1,686 0.0022% | $174.13 | $293,584 | -71.05% | |
| 2021-12-07 | Sale | Glenn Gregory M | President, R&D | 8,250 0.0101% | $170.14 | $1.4M | -70.62% | |
| 2021-12-01 | Sale | Herrmann John A III | EVP, Chief Legal Officer | 5,000 0.0067% | $196.19 | $980,944 | -71.88% | |
| 2021-11-30 | Sale | Glenn Gregory M | President, R&D | 8,942 0.0115% | $203.20 | $1.82M | -73.89% | |
| 2021-11-29 | Sale | Herrmann John A III | EVP, Chief Legal Officer | 5,000 0.0078% | $228.72 | $1.14M | -71.88% | |
| 2021-11-26 | Sale | Glenn Gregory M | President, R&D | 2,083 0.0028% | $218.07 | $454,247 | -74.84% | |
| 2021-11-23 | Sale | Glenn Gregory M | President, R&D | 8,250 0.0108% | $199.50 | $1.65M | -72.49% | |
| 2021-11-16 | Sale | Glenn Gregory M | President, R&D | 8,250 0.0108% | $169.48 | $1.4M | -66.87% | |
| 2021-11-15 | Sale | Glenn Gregory M | President, R&D | 1,183 0.0016% | $172.02 | $203,496 | -67.05% |
Insider Historical Profitability
42.68%
| YOUNG JAMES F | 61760 0.0527% | $13.11 | 5 | 9 | +66.45% | |
| Dubovsky Filip | President, R&D | 66613 0.0277% | $13.11 | 0 | 2 | |
| Cadila Pharmaceuticals Ltd | 10 percent owner | 9500000 7.9973% | $13.11 | 0 | 3 | |
| SJ STRATEGIC INVESTMENTS LLC | 10 percent owner | 4001500 3.3685% | $13.11 | 0 | 4 | |
| Monath Thomas P | director | 3225366 2.7152% | $13.11 | 1 | 0 | <0.0001% |
| TANANBAUM JAMES B | director | 3151818 2.6533% | $13.11 | 1 | 0 | <0.0001% |
| Modi Rajiv I. | director | 2500000 2.1046% | $13.11 | 0 | 17 | |
| DOUGLAS RICHARD | director | 550000 0.463% | $13.11 | 7 | 0 | +19.72% |
| ODONNELL DENIS M | director | 221495 0.1865% | $13.11 | 0 | 2 | |
| BOUDREAUX GAIL | director | 200000 0.1684% | $13.11 | 1 | 0 | <0.0001% |
| Singhvi Rahul | President, CEO | 113104 0.0952% | $13.11 | 2 | 2 | <0.0001% |
| Hahn Timothy Jon | SVP, Manufacturing | 110485 0.093% | $13.11 | 7 | 0 | +72.19% |
| LAMBERT JOHN A | director | 80000 0.0673% | $13.11 | 1 | 1 | <0.0001% |
| Robinson Jim | VP, Tech. & Quality Operations | 77590 0.0653% | $13.11 | 3 | 0 | <0.0001% |
| Wilson Russell P | SVP, Business Development | 64939 0.0547% | $13.11 | 3 | 0 | +32.34% |
| MOTT DAVID M | director | 40000 0.0337% | $13.11 | 0 | 1 | |
| PHILLIPS BARCLAY A | SVP, Chief Financial Officer | 38669 0.0326% | $13.11 | 12 | 2 | +23.52% |
| MARSH JOHN O JR | director | 36000 0.0303% | $13.11 | 2 | 0 | +156.16% |
| SIMS NELSON M | Former President & CEO | 25000 0.021% | $13.11 | 2 | 0 | <0.0001% |
| Erck Stanley C | President and CEO | 23879 0.0201% | $13.11 | 12 | 11 | +13.48% |
| Stigliano Len F | VP, CFO, Treasurer | 20554 0.0173% | $13.11 | 2 | 0 | <0.0001% |
| DRISCOLL FREDERICK W | VP, CFO & Treasurer | 20000 0.0168% | $13.11 | 1 | 0 | +0.73% |
| Heaton Penny | VP & Chief Medical Officer | 18667 0.0157% | $13.11 | 2 | 1 | <0.0001% |
| Glenn Gregory M | President, R&D | 14473 0.0122% | $13.11 | 23 | 43 | +76.53% |
| LAZARUS J MICHAEL MD | director | 11927 0.01% | $13.11 | 2 | 1 | +29.29% |
| Hage Raymond Joseph | Sr. VP. Commercial Operations | 11512 0.0097% | $13.11 | 0 | 5 | |
| Johnston Thomas Scott | Vice President, Strategy | 11000 0.0093% | $13.11 | 1 | 1 | <0.0001% |
| MCMANUS MICHAEL A JR | director | 5951 0.005% | $13.11 | 6 | 3 | +25.72% |
| LYNCH FORD R | Sr. VP Marketing and Sales | 4300 0.0036% | $13.11 | 1 | 0 | <0.0001% |
| Herrmann John A III | EVP, Chief Legal Officer | 3845 0.0032% | $13.11 | 5 | 22 | +7.6% |
| King Rachel K. | director | 2800 0.0024% | $13.11 | 2 | 0 | <0.0001% |
| Trizzino John | EVP, CCO and CBO | 2546 0.0021% | $13.11 | 10 | 22 | <0.0001% |
| KELLY MITCHELL J | director | 500 0.0004% | $13.11 | 0 | 7 | |
| EVANS GARY C | director | 0 0% | $13.11 | 20 | 15 | +105.58% |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| State Street | $80.81M | 12.04 | 16.91M | +0.78% | +$624,722.10 | <0.01 | |
| The Vanguard Group | $64.5M | 9.61 | 13.49M | -7.33% | -$5.1M | <0.01 | |
| BlackRock | $45.07M | 6.72 | 9.43M | +11.76% | +$4.74M | <0.01 | |
| Shah Capital Management | $38.8M | 5.78 | 8.12M | +4.33% | +$1.61M | 11.05 | |
| Geode Capital Management | $12.37M | 1.84 | 2.59M | +12.63% | +$1.39M | <0.01 | |
| Morgan Stanley | $8.94M | 1.33 | 1.87M | -74.17% | -$25.67M | <0.01 | |
| Citigroup | $8.39M | 1.25 | 1.76M | +47.08% | +$2.69M | 0.01 | |
| Rafferty Asset Management Llc | $8.04M | 1.2 | 1.68M | +4.39% | +$338,514.82 | 0.02 | |
| Coatue Management | $7.26M | 1.08 | 1.52M | 0% | +$0 | 0.03 | |
| Allianz Asset Management Gmbh | $7.02M | 1.05 | 1.47M | +131.55% | +$3.99M | 0.01 | |
| Tsp Capital Management Group Llc | $6.58M | 0.98 | 1.38M | +23.86% | +$1.27M | 2.18 | |
| Farallon Capital | $5.41M | 0.81 | 1.13M | New | +$5.41M | 0.04 | |
| Bank of America | $5.16M | 0.77 | 1.08M | -18.6% | -$1.18M | <0.01 | |
| Northern Trust | $5.09M | 0.76 | 1.06M | +6.22% | +$298,276.79 | <0.01 | |
| UBS | $4.76M | 0.71 | 995,490 | +18,926.95% | +$4.73M | <0.01 | |
| Goldman Sachs | $4.48M | 0.67 | 936,495 | +8.42% | +$347,797.57 | <0.01 | |
| Charles Schwab | $4.45M | 0.66 | 930,220 | +22.34% | +$812,059.93 | <0.01 | |
| Bank of Montreal | $5.07M | 0.47 | 660,351 | -22.83% | -$1.5M | <0.01 | |
| ROCK SPRINGS CAPITAL MANAGEMENT, LP | $2.57M | 0.38 | 537,625 | 0% | +$0 | 0.07 | |
| Credit Suisse | $1.94M | 0.29 | 405,846 | -10.37% | -$224,330.08 | <0.01 | |
| BNY Mellon | $1.9M | 0.28 | 397,470 | +1.28% | +$24,052.95 | <0.0001 | |
| National Bank Of Canada Fi | $3.45M | 0.28 | 388,044 | +17,418.92% | +$3.43M | 0.01 | |
| SG Americas Securities, LLC | $1.71M | 0.26 | 358,196 | +108.72% | +$891,750.71 | 0.01 | |
| Susquehanna Fundamental Investments Llc | $1.5M | 0.22 | 313,580 | New | +$1.5M | 0.07 | |
| Citadel Advisors LLC | $1.39M | 0.21 | 290,651 | New | +$1.39M | <0.01 | |
| Nuveen | $1.27M | 0.19 | 266,638 | 0% | +$0 | <0.0001 | |
| Vontobel Holding Ltd | $1.24M | 0.18 | 258,731 | +24.2% | +$240,959.77 | 0.01 | |
| Profund Advisors Llc | $1.23M | 0.18 | 257,058 | +0.16% | +$1,945.46 | 0.03 | |
| Quinn Opportunity Partners Llc | $1.22M | 0.18 | 255,001 | 0% | +$0 | 0.15 | |
| Barclays | $1.21M | 0.18 | 253,426 | -69.16% | -$2.72M | <0.01 | |
| Susquehanna International Group | $1.2M | 0.18 | 250,951 | +568.51% | +$1.02M | <0.01 | |
| Swiss National Bank | $1.01M | 0.15 | 211,000 | +17.09% | +$147,224.00 | <0.01 | |
| Monaco Asset Management Sam | $902,942.00 | 0.14 | 188,900 | +181.31% | +$581,969.78 | 0.42 | |
| Invesco | $720,299.00 | 0.11 | 150,690 | +358.69% | +$563,266.27 | <0.0001 | |
| RhumbLine Advisers | $686,319.00 | 0.1 | 143,585 | +9.88% | +$61,684.35 | <0.01 | |
| JPMorgan Chase | $565,432.00 | 0.08 | 118,291 | -26.17% | -$200,392.30 | <0.0001 | |
| D. E. Shaw & Co. | $546,598.00 | 0.08 | 114,351 | +11.53% | +$56,490.06 | <0.01 | |
| AllianceBernstein | $534,069.00 | 0.08 | 111,730 | -0.58% | -$3,121.34 | <0.0001 | |
| Ohio Strs | $532,000.00 | 0.08 | 111,300 | +11.08% | +$53,056.60 | <0.01 | |
| CalSTRS | $513,903.00 | 0.08 | 107,511 | +11.34% | +$52,336.26 | <0.01 | |
| Legal & General | $507,288.00 | 0.08 | 106,127 | +6.83% | +$32,418.02 | <0.0001 | |
| Guggenheim Capital | $446,371.00 | 0.07 | 93,383 | +11.17% | +$44,855.55 | <0.01 | |
| Zurich Cantonal Bank | $445,558.00 | 0.07 | 93,213 | +6.24% | +$26,165.71 | <0.01 | |
| Jane Street Capital | $438,231.00 | 0.07 | 91,680 | -91.64% | -$4.8M | <0.0001 | |
| Banco Bilbao Vizcaya Argentaria | $415,142.00 | 0.06 | 86,936 | -5.54% | -$24,353.83 | 0.01 | |
| Ubs Asset Management Americas Inc | $411,390.00 | 0.06 | 86,065 | +21.57% | +$73,000.04 | <0.0001 | |
| State Board of Administration of Florida | $579,438.00 | 0.06 | 83,613 | +236.24% | +$407,109.72 | <0.01 | |
| E Fund Management Co Ltd | $380,077.00 | 0.06 | 79,514 | -8.14% | -$33,670.33 | 0.02 | |
| Advisor Group Holdings Inc | $362,380.00 | 0.05 | 75,891 | -5.77% | -$22,175.13 | <0.01 | |
| Advisory Services Network Llc | $327,765.00 | 0.05 | 68,570 | +342,750% | +$327,669.40 | 0.01 |